{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:55:42Z","timestamp":1788994542165,"version":"build-2803163510"},"reference-count":16,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["RS\/2022\/DTS\/24104"],"award-info":[{"award-number":["RS\/2022\/DTS\/24104"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>After a period of low SARS\u2010CoV\u20102 activity, viral circulation increased in Europe from May 2024, driven by immune\u2010evasive KP sublineages of the JN.1 variant. We estimated vaccine effectiveness (VE) of the XBB.1.5 dose administered in autumn 2023 against COVID\u201019\u2010related hospitalisations and deaths in individuals 65\u2009years of age or older during this period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multi\u2010country cohort study across six EU nations in the VEBIS\u2010EHR network using linked electronic health records. VE against COVID\u201019\u2010related hospitalisation and death during June\u2013August 2024 was estimated using Cox regression in a two\u2010stage analysis, adjusting for demographics, comorbidities and prior vaccination history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among individuals 65\u201379 and \u2265\u200980\u2009years old, respectively, VE of the XBB.1.5 dose \u2265\u20096\u2009months post administration was 13% (95% CI: \u221212% to 33%) and 7% (95% CI: \u22127% to 19%) against hospitalisation and 39% (95% CI: \u22127% to 65%) and 3% (95% CI: \u221223% to 23%) against deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>XBB.1.5 vaccination provided minimal residual protection against severe COVID\u201019 outcomes among adults aged \u2265\u200965\u2009years more than 6\u2009months after vaccination, during the summer 2024 period of increased SARS\u2010CoV\u20102 activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/irv.70198","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:50:09Z","timestamp":1764330609000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of the 2023 Autumn XBB.1.5 COVID\u201019 Booster During Summer 2024 in the EU\/EEA: A VEBIS Electronic Health Record Network Study"],"prefix":"10.1111","volume":"19","author":[{"given":"James","family":"Humphreys","sequence":"first","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nicolay","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation European Centre for Disease Prevention and Control (ECDC)  Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Braeye","sequence":"additional","affiliation":[{"name":"Sciensano  Elsene Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaak","family":"Van\u00a0Evercooren","sequence":"additional","affiliation":[{"name":"Sciensano  Elsene Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian\u00a0Holm","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Prevention Statens Serum Institut  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida\u00a0Rask","family":"Moustsen\u2010Helms","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Prevention Statens Serum Institut  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sacco","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Istituto Superiore di Sanit\u00e0  Rome Italy"},{"name":"European Programme on Intervention Epidemiology Training (EPIET) European Centre for Disease Prevention and Control  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Istituto Superiore di Sanit\u00e0  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra\u2014IdiSNA  Pamplona Spain"},{"name":"CIBER on Epidemiology and Public Health  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Mart\u00ednez\u2010Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra\u2014IdiSNA  Pamplona Spain"},{"name":"CIBER on Epidemiology and Public Health  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[{"name":"Departamento de Epidemiologia e Centro de Estudos de Vectores e Doen\u00e7as Infecciosas Dr. Francisco Cambournac Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Soares","sequence":"additional","affiliation":[{"name":"Departamento de Epidemiologia e Centro de Estudos de Vectores e Doen\u00e7as Infecciosas Dr. Francisco Cambournac Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard","family":"Ljung","sequence":"additional","affiliation":[{"name":"Swedish Medical Products Agency  Uppsala Sweden"},{"name":"Institute of Environmental Medicine Karolinska Institutet  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicklas","family":"Pihlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Swedish Medical Products Agency  Uppsala Sweden"},{"name":"Institute of Environmental Medicine Karolinska Institutet  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Kissling","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Nardone","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Monge","sequence":"additional","affiliation":[{"name":"Department of Communicable Diseases, National Centre of Epidemiology Institute of Health Carlos III  Madrid Spain"},{"name":"CIBER on Infectious Diseases  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bacci","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation European Centre for Disease Prevention and Control (ECDC)  Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Nunes","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VEBIS\u2010EHR working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02949-0"},{"key":"e_1_2_11_3_1","unstructured":"European Centre for Disease Prevention and Control \u201cCommunicable Disease Threats Report 10\u201316 August 2024 Week 33 [Internet] \u201d (2024) https:\/\/www.ecdc.europa.eu\/en\/publications\u2010data\/communicable\u2010disease\u2010threats\u2010report\u201010\u201016\u2010august\u20102024\u2010week\u201033."},{"key":"e_1_2_11_4_1","unstructured":"GISAID via CoVariants.org. Our World in Data \u201cSARS\u2010CoV\u20102 Sequences by Variant \u201d (2024) https:\/\/ourworldindata.org\/grapher\/covid\u2010variants\u2010bar?country=CAN~ITA~BEL~GBR~USA~ESP~PRT~SWE~DNK."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty407"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00298-6"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00415-8"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00152-0"},{"key":"e_1_2_11_9_1","unstructured":"European Centre for Disease Prevention and Control \u201cERVISS [Internet] \u201d (2024) https:\/\/erviss.org\/."},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13292"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2428800"},{"key":"e_1_2_11_12_1","unstructured":"European Centre for Disease Prevention and Control \u201cProtocol for a COVID\u201019 Vaccine Effectiveness Estimation Using Health Data Registries VEBIS Multi\u2010Country Study\u2014Version 2.0 [Internet] \u201d (2024) https:\/\/www.ecdc.europa.eu\/en\/publications\u2010data\/protocol\u2010covid\u201019\u2010vaccine\u2010effectiveness\u2010estimation\u2010using\u2010health\u2010data\u2010registries."},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","unstructured":"S.Carazo D. M.Skowronski N.Brousseau et\u00a0al. \u201cMonovalent mRNA XBB.1.5 Vaccine Effectiveness Against COVID\u201019 Hospitalization in Quebec Canada: Impact of Variant Replacement and Waning Protection During 10\u2010Month Follow\u2010Up [Internet] \u201d preprint medRxiv November 13 2024 https:\/\/www.medrxiv.org\/content\/10.1101\/2024.11.13.24317190v1.","DOI":"10.1101\/2024.11.13.24317190"},{"key":"e_1_2_11_14_1","unstructured":"UK Health Security Agency. GOV.UK. \u201cCOVID\u201019 Vaccine Quarterly Surveillance Reports (September 2021 to November 2024) \u201d (2024) https:\/\/assets.publishing.service.gov.uk\/media\/6735ddce0b168c11ea8230f2\/Vaccine_surveillance_report_2024_week_46.pdf."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyae077"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwad191"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwad017"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70198","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.70198","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.70198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:32:06Z","timestamp":1773109926000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.70198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1111\/irv.70198"],"URL":"https:\/\/doi.org\/10.1111\/irv.70198","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2025-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70198"}}